This Highly Rated Medical-Research Stock Just Topped Quarterly Views [Investor's Business Daily]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Investors Business Daily
Related news Iqvia Holdings ( IQV ) jumped early Monday after the medical-research company's third-quarter earnings topped expectations. In morning trading on the stock market today , Iqvia stock lifted about 2%, near 129.15. Earlier, shares popped as much as 6.8% to touch a record high. Iqvia stock is the third largest medical-research company by market cap. For the third quarter, Iqvia reported adjusted earnings of $1.42 per share on $2.59 billion in sales, rising 19.3% and 5.2%, respectively. On average, analysts had expected adjusted profit of $1.39 a share and $2.58 billion in sales. The medical-research company also guided to $10.3 billion to $10.35 billion in full-year sales under current foreign exchange rates. It sees adjusted earnings of $5.45 to $5.55 a share. Analysts modeled $10.37 billion in sales and $5.50 in earnings per share. Iqvia stock is highly rated. It has an Investor's Business Daily Composite Rating of 98 out of a best-possible 99, putting it in the top 2% of
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Strategies for Biomarker-Driven Sub-population Optimization in Clinical Trials, Upcoming Webinar Hosted by XtalksPR Web
- Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly [Yahoo! Finance]Yahoo! Finance
- IQVIA to Announce First-Quarter 2024 Results on May 2, 2024Business Wire
- Global In Vivo CRO Market Analysis Report 2024-2030, Featuring IQVIA, Crown Bioscience, Taconic Biosciences, PsychoGenics, Evotec, Janvier Labs, Biocytogen Boston, GemPharmatech and Parexel [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 2/14/24 - Beat
IQV
Sec Filings
- 4/17/24 - Form 8-K
- 3/4/24 - Form 4
- 3/4/24 - Form 4
- IQV's page on the SEC website